NCT02229968View on ClinicalTrials.gov

Efficacy of Amicar for Children Having Craniofacial Surgery

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

January 31, 2027

Study Completion Date

March 31, 2027

Conditions
Craniosynostosis
Interventions
DRUG

Amicar (ε-aminocaproic acid)

DRUG

normal saline

Trial Locations (1)

37232

Vanderbilt University Medical Center, Nashville

Sponsors
All Listed Sponsors
lead

Children's National Research Institute

OTHER

NCT02229968 - Efficacy of Amicar for Children Having Craniofacial Surgery | Biotech Hunter | Biotech Hunter